The chemicals acetophenone, 2′-hydroxyacetophenone, 2′-chloroacetophenone, 3′-chloroacetophenone, 3′-hydroxyacetophenone, 3′-methoxyacetophenone, 4′-hydroxyacetophenone, 4′-chloroacetophenone, 4′-bromoacetophenone, 4′-methylacetophenone, 4′-methoxyacetophenone, benzaldehyde, 4-bromobenzaldehyde, 4-chlorobenzaldehyde, 4-methylbenzaldehyde, 4-methoxybenzaldehyde, 3-nitrobenzaldehyde, 4-nitrobenzaldehyde, trans-cinnamaldehyde, methyl trans-cinnamate, benzylideneacetone, trans-β-nitrostyrene were purchased from Sigma-Aldrich (St. Louis, MO, USA). 1,2-Dichloroethane, dichloromethane, deuterated chloroform (CDCl3-d1), ethyl acetate, n-hexane, tetrahydrofuran and toluene were purchased from Merck (Darmstadt, Germany) and were of analytical grade. (E)-ocimene (β-trans-ocimene) was prepared according to the known method.
S1
Analytical thin-layer chromatography (TLC) was carried out on Merck precoated aluminum silica gel sheets (Kieselgel 60 F254) . Column chromatography was performed with silica gel 60 (230-400 mesh) from Merck. All melting points were taken on a Stuart melting point apparatus SMP30 (Staffordshire, UK). NMR spectra were obtained using Jeol ECA 400 (400 MHz) (Jeol Ltd., Akishima, Tokyo, Japan) and Bruker Avance III HD (400 MHz) (Bruker Biospin Corp., Billerica, USA) NMR spectrometers with tetramethylsilane as the internal standard. All chemical shifts are reported in ppm. MS analysis was performed on an Agilent 6500 series accurate mass Q-TOF (Agilent Technologies, Santa Clara, CA, USA). (E)-Ocimene (5 equiv) was added, and the mixture was stirred at r.t for 24 h or until all the chalcone was consumed. The mixture was then poured into ice-water acidified with 3N aqueous HCl to pH 2-3. The resulting mixture was extracted with EtOAc, and the organic phase was dried (Na2SO4) and concentrated under reduced pressure. The crude product was purified by column chromatography (silica gel, 5-20% EtOAc-hexane). The structures of 3a−3r were confirmed by 1 H,
General procedure for synthesis of panduratin A derivatives 3a−3r

13
C NMR and HRMS spectroscopic techniques. [3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl](phenyl)methanone (3) Pale brown solid; yield: 124 mg (72%). .99 (t, J = 6.9 Hz, 1 H), 7.09-7.14 (m, 4 H), 7.32 (t, J = 7.8 Hz, 2 H), 7.40 (t, J = 7.3 Hz, 1 H), 7.79 (d, J = 7.8 Hz, 2 H).
C NMR (100 MHz, CDCl3): δ = 17. 7, 22.8, 25.6, 28.7, 35.0, 36.9, 42.8, 50.3, 121.3, 123.7, 125.7, 127.0, 127.9, 128.3, 128.4, 131.9, 132.5, 136.5, 137.4, 146.3, 200.6 .
HRMS (ESI): m/z [M + H]
+ calcd for C25H29O: 345.2218; found: 345.2225.
Yellow oil; yield: 32 mg (17%). 1 H NMR (400 MHz, CDCl3): δ = 1.50 (s, 3 H), 1.58 (s, 3 H), 1.68 (s, 3 H), 2.11-2.22 (m, 2 H), 2.25-2.32 (m, 2 H), 2.39-2.46 (m, 1 H), 3.34 (td, J = 9.8, 7.1 Hz, 1 H), 3.96 (dd, J = 10.2, 4.2 Hz, 1 H), 4.97 (t, J = 6.6 Hz, 1 H), 5.40 (br s, 1 H), 7.04-7.08 (m, 1 H), 7.14-7.30 (m, 8 H).
13
C NMR (100 MHz, CDCl3): δ = 18. 0, 23.1, 25.8, 29.0, 33.8, 37.4, 40.6, 55.3, 121.0, 123.6, 126.0, 126.6, 127.7, 128.2, 129.4, 130.8, 131.5, 131.5, 132.0, 136.9, 139.0, 145.7, 202.7 8, 22.7, 25.6, 28.7, 34.9, 37.0, 43.0, 50.6, 121.4, 123.7, 125.9, 126.0, 127.1, 128.1, 128.4, 129.8, 132.3, 132.4, 134.8, 136.3, 139.1, 146.0, 199 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.8, 25.7, 28.8, 35.0, 37.1, 43.0, 50.6, 55.3, 112.5, 119.0, 120.5, 121.3, 123.8, 125.8, 127.1, 128.3, 129.4, 131.9, 136.6, 138.9, 146.4, 159.8, 200 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.8, 25.7, 28.8, 35.0, 37.0, 43.0, 50.5, 121.4, 123.7, 125.9, 127.1, 128.4, 128.8, 129.4, 132.2, 135.8, 136.5, 138.9, 146.2, 199 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.8, 25.7, 28.8, 35.0, 37.0, 43.0, 50.5, 121.4, 123.7, 125.9, 127.1, 127.6, 128.4, 129.5, 131.8, 132.2, 136.2, 136.4, 146.1, 199.6 
C NMR (100 MHz, CDCl3): δ = 17. 8, 21.5, 22.9, 25.7, 28.9, 35.1, 37.0, 42.9, 50.3, 121.3, 123.8, 125.7, 127.1, 128.1, 128.3, 129.2, 131.8, 135.1, 136.7, 143.2, 146.5, 200. 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.9, 25.7, 28.9, 35.1, 37.1, 43.1, 50.1, 55.4, 113.6, 121.3, 123.9, 125.7, 127.1, 128.3, 130.2, 130.8, 131.8, 136.8, 146.5, 163.0, 199. 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.7, 25.6, 28.7, 35.0, 36.9, 43.1, 50.7, 120.8, 121.0, 121.9, 123.3, 127.9, 128.6, 129.1, 132.3, 132.9, 133.8, 136.8, 137.1, 148.3, 148.7, 200. 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.8, 25.7, 28.8, 35.0, 36.6, 43.0, 50.5, 119.4, 121.1, 123.6, 128.0, 128.6, 128.9, 131.4, 132.1, 132.7, 136.7, 137.3, 145.5, 200 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.8, 25.7, 28.8, 35.0, 37.0, 43.0, 50.5, 121.4, 123.7, 125.9, 127.1, 128.4, 128.8, 129.4, 132.2, 135.9, 136.5, 138.9, 146.2, 199 8, 20.9, 22.8, 25.7, 28.8, 35.1, 36.6, 42.8, 50.5, 121.4, 123.8, 127.0, 128.0, 128.5, 129.1, 131.9, 132.5, 135.1, 136.6, 137.6, 143.3, 200.7 . 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.8, 25.7, 28.8, 35.0, 36.2, 42.8, 50.7, 55.1, 113.8, 121.4, 123.8, 128.0, 128.0, 128.5, 131.9, 132.5, 136.6, 137.6, 138.4, 157.5, 200. 
C NMR (100 MHz, CDCl3): δ = 17. 8, 22.7, 25.6, 28.7, 34.8, 37.2, 43.2, 50.6, 120.7, 123.2, 123.7, 127.9, 127.9, 128.6, 132.4, 133.0, 136.8, 137.0, 146.1, 154.6, 200. (4-Methoxyphenyl)[3-methyl-2-(3-methylbut-2-en-1-yl)-6-(4-bromophenyl)cyclohex-3-en-1-yl]methanone (3n) 1
